单词tissue plasminogen activator
网络: 组织纤溶酶原激活物；组织型纤溶酶原激活剂；组织型纤溶酶原激活物
Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: a systematic review.
急性缺血性卒中患应用重组组织纤溶酶原激活剂治疗的效用成本：一项系统性回顾
A drug called tissue plasminogen activator -- tPA -- dissolves clots and restores blood flow.
而一种称为组织纤维蛋白溶酶原激活物（tPA）的药物可以溶解血块，并恢复血液流通。
Because of extensive purpura fulminans with skin necrosis recombinant tissue plasminogen activator (rt-PA) was used.
由于广泛的暴发性紫癜皮肤坏死与重组组织型纤溶酶原激活剂（酶原激活剂）的使用。
NIHSS scores were determined before tissue plasminogen activator bolus and at 60 and 120 minutes in both data sets.
在两个试验中，在组织纤维蛋白溶酶原激活剂使用前，都先用NIHSS评分。
Intravenous thrombolysis therapies in acute myocardial infarction with the reconstructive tissue plasminogen activator in prehospital care
急性心肌梗死院前应用重组组织型纤溶酶原激活剂溶栓研究
Clinical Thrombolytic Trial of A New Type of Tissue-Plasminogen Activator in Patients with Acute Myocardial Infarction
一种新的人组织纤溶酶原激活剂对急性心肌梗死的溶栓效果
Discussion for the Problems in Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction
急性脑梗死静脉溶栓治疗的难点与对策
Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction
尿激酶与重组织型纤溶酶原激活剂静脉溶栓治疗急性心肌梗死
The efficacy of thrombolysis with recombinant tissue plasminogen activator as compared with urokinase for acute myocardial infarction
重组组织型纤溶酶原激活剂和尿激酶治疗急性心肌梗死的疗效比较
Combined intravenous and intra-arterial infusion of recombinant tissue plasminogen activator for treatment of acute ischemic stroke
重组组织型纤溶酶原激活剂动静脉联合溶栓治疗急性缺血性卒中